Available from: [LINK] Patient Professional
GLP-1 also communicates with the brain to suppress hunger and decelerate stomach emptying, leaving you feeling full longer
(November 1999)
Semaglutide commonly causes nausea, constipation, and appetite loss, while lisinopril may cause dizziness, dry cough, or elevated potassium
When to Consider a Higher Starting Dose Patients with prior GLP-1 exposure, such as those who previously took semaglutide, may skip the 2.5 mg phase and start at 5 mg if their PlexusDx provider determines they tolerated lower doses without serious side effects
This condition, mainly caused by bacterial infections, oxidative stress, high-fat diet, exposure to alcohol or chronic allergens, and dysbiosis, appear to be highly connected with the development and/or progression of several metabolic and autoimmune systemic diseases, including obesity, non-alcoholic fatty liver disease (NAFLD), neurodegeneration, cardiovascular disease, inflammatory bowel disease, and type 1 diabetes mellitus (T1D)
